RecruitingNCT05257954

Frailty in Patient Undergoing Percutaneous Left Atrial Appendage Closure.

Frailty in Patient Undergoing Percutaneous Left Atrial Appendage Closure The Frail-LAAC Study


Sponsor

Josep Rodes-Cabau

Enrollment

500 participants

Start Date

Mar 1, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

To assess the prevalence and severity of frailty in patients undergoing LAAC, as well as its association to peri-procedural and long-term outcomes and quality of life.


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • Transcatheter LAAC with any approved device
  • Age ≥18 years old

Exclusion Criteria2

  • Unable to provide informed consent
  • Severe neuropsychiatric impairment

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

IUCPQ_UL

Québec, Quebec, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05257954


Related Trials